Your browser doesn't support javascript.
loading
Dysregulated Repeat Element Viral-like Immune Response in Hepatocellular Carcinoma.
Coley, Avril K; Lu, Chenyue; Pankaj, Amaya; Emmett, Matthew J; Lang, Evan R; Song, Yuhui; Xu, Katherine H; Xu, Nova; Patel, Bidish K; Chougule, Abhijit; Nieman, Linda T; Aryee, Martin J; Ferrone, Cristina R; Deshpande, Vikram; Franses, Joseph W; Ting, David T.
Affiliation
  • Coley AK; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Lu C; Department of Surgery, Massachusetts General Hospital Harvard Medical School; Boston, MA, USA.
  • Pankaj A; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Emmett MJ; Health Sciences and Technology Program; Cambridge, MA, USA.
  • Lang ER; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Song Y; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Xu KH; Department of Medicine, Massachusetts General Hospital, Harvard Medical School; Boston, MA, USA.
  • Xu N; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Patel BK; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Chougule A; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Nieman LT; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Aryee MJ; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Ferrone CR; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Deshpande V; Mass General Cancer Center, Harvard Medical School; Charlestown, MA, USA.
  • Franses JW; Department of Biostatistics, Harvard T.H. Chan School of Public Health; Boston, MA, USA.
  • Ting DT; Department of Data Sciences, Dana-Farber Cancer Institute; Boston, MA, USA.
bioRxiv ; 2023 Dec 05.
Article in En | MEDLINE | ID: mdl-38105940
ABSTRACT

Purpose:

Dysregulation of viral-like repeat RNAs are a common feature across many malignancies that are linked with immunological response, but the characterization of these in hepatocellular carcinoma (HCC) is understudied. In this study, we performed RNA in situ hybridization (RNA-ISH) of different repeat RNAs, immunohistochemistry (IHC) for immune cell subpopulations, and spatial transcriptomics to understand the relationship of HCC repeat expression, immune response, and clinical outcomes. Experimental

Design:

RNA-ISH for LINE1, HERV-K, HERV-H, and HSATII repeats and IHC for T-cell, Treg, B-cell, macrophage, and immune checkpoint markers were performed on 43 resected HCC specimens. Spatial transcriptomics on tumor and vessel regions of interest was performed on 28 specimens from the same cohort.

Results:

High HERV-K and high LINE1 expression were both associated with worse overall survival. There was a positive correlation between LINE1 expression and FOXP3 T-regulatory cells (r = 0.51 p < 0.001) as well as expression of the TIM3 immune checkpoint (r = 0.34, p = 0.03). Spatial transcriptomic profiling of HERV-K high and LINE-1 high tumors identified elevated expression of multiple genes previously associated with epithelial mesenchymal transition, cellular proliferation, and worse overall prognosis in HCC including SSX1, MAGEC2, and SPINK1.

Conclusion:

Repeat RNAs may serve as useful prognostic biomarkers in HCC and may also serve as novel therapeutic targets. Additional study is needed to understand the mechanisms by which repeat RNAs impact HCC tumorigenesis.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Affiliation country: Country of publication: